SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Intersect ENT, Inc. – XENT

excerpt, News, stream

NEW YORK, July 14, 2019 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Intersect ENT, Inc. (“Intersect” or the “Company”) (NASDAQ:XENT). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Intersect and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

[Click here for information about joining the class action]

On August 1, 2018, before the market opened, Intersect disclosed that …

Full story available on Benzinga.com

Leave a Reply